200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 196597-26-9

196597-26-9

196597-26-9 | (S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide

CAS No: 196597-26-9 Catalog No: AG0038WF MDL No:MFCD08067736

Product Description

Catalog Number:
AG0038WF
Chemical Name:
(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide
CAS Number:
196597-26-9
Molecular Formula:
C16H21NO2
Molecular Weight:
259.3434
MDL Number:
MFCD08067736
IUPAC Name:
N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide
InChI:
InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1
InChI Key:
YLXDSYKOBKBWJQ-LBPRGKRZSA-N
SMILES:
CCC(=O)NCC[C@@H]1CCc2c1c1CCOc1cc2
UNII:
901AS54I69

Properties

Complexity:
331  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
259.157g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
259.349g/mol
Monoisotopic Mass:
259.157g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
38.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.7  

Literature

Title Journal
Cardiovascular effects of melatonin receptor agonists. Expert opinion on investigational drugs 20121101
Ramelteon dose escalation in a patient with substance misuse. Journal of clinical psychopharmacology 20121001
Ramelteon ingestions reported to Texas poison centers, 2005-2009. The Journal of emergency medicine 20120901
Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system. Central nervous system agents in medicinal chemistry 20120901
Emerging treatment for chronic migraine and refractory chronic migraine. Expert opinion on emerging drugs 20120901
Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. International journal of clinical practice 20120901
Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer. Molecular carcinogenesis 20120801
Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon. Chronobiology international 20120801
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clinical pharmacology and therapeutics 20120601
Pharmacotherapy of insomnia. Expert opinion on pharmacotherapy 20120601
[New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance]. Nihon rinsho. Japanese journal of clinical medicine 20120601
Melatonin and its analogs in insomnia and depression. Journal of pineal research 20120501
[Delirium, insomnia in hospitalization and ramelteon]. Nihon rinsho. Japanese journal of clinical medicine 20120501
[Report of the 5th meeting of Japanese Child Sleep Association]. No to hattatsu = Brain and development 20120501
Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders. CNS & neurological disorders drug targets 20120301
Chronic ramelteon treatment in a mouse model of Alzheimer's disease. Archives italiennes de biologie 20120301
Augmentation with ramelteon to achieve remission in geriatric major depression. Psychiatry and clinical neurosciences 20120201
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease. Parkinson's disease 20120101
Health care costs in US patients with and without a diagnosis of osteoarthritis. Journal of pain research 20120101
Emerging targets for the pharmacological treatment of depression: focus on melatonergic system. Current medicinal chemistry 20120101
The relationship of primary health care use with persistence of insomnia: a prospective cohort study. BMC family practice 20120101
Hypnotics' association with mortality or cancer: a matched cohort study. BMJ open 20120101
Circadian and wakefulness-sleep modulation of cognition in humans. Frontiers in molecular neuroscience 20120101
cGMP-phosphodiesterase inhibition enhances photic responses and synchronization of the biological circadian clock in rodents. PloS one 20120101
Gender differences in highway driving performance after administration of sleep medication: a review of the literature. Traffic injury prevention 20120101
Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. TheScientificWorldJournal 20120101
Recent progress in the development of agonists and antagonists for melatonin receptors. Current medicinal chemistry 20120101
Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives. Journal of medicinal chemistry 20111222
Melatonin receptor agonists: new options for insomnia and depression treatment. CNS neuroscience & therapeutics 20111201
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. Journal of clinical psychopharmacology 20111001
Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia. Sleep medicine 20111001
Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia. Expert review of neurotherapeutics 20111001
The challenges of interpreting residual effects of hypnotics. Sleep 20111001
Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep 20111001
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection. Therapeutic advances in neurological disorders 20110901
An historical view of the pineal gland and mental disorders. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20110801
Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands. Journal of medicinal chemistry 20110623
Ramelteon and improved insomnia in alcohol-dependent patients: a case series. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110615
Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Progress in neuro-psychopharmacology & biological psychiatry 20110601
Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration. Sleep medicine 20110601
Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization. Current neuropharmacology 20110601
1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists. Journal of medicinal chemistry 20110512
Insomnia: a therapeutic review for pharmacists. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110501
Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands. Bioorganic & medicinal chemistry letters 20110215
Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder. Journal of affective disorders 20110201
Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice. Chronobiology international 20110201
Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep medicine 20110201
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. Sleep medicine 20110201
Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study. Expert review of neurotherapeutics 20110201
A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance. International clinical psychopharmacology 20110101
Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value. International journal of Alzheimer's disease 20110101
Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Research in developmental disabilities 20110101
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications. Neuroendocrinology 20110101
Pharmacological advances in the treatment of insomnia. Current pharmaceutical design 20110101
Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm? Journal of the American Society of Hypertension : JASH 20110101
Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). International journal of general medicine 20110101
Melatonin in mitochondrial dysfunction and related disorders. International journal of Alzheimer's disease 20110101
Clinical uses of melatonin in pediatrics. International journal of pediatrics 20110101
Treatment of delirium with ramelteon: initial experience in three patients. General hospital psychiatry 20110101
Efficient synthesis of [¹¹C]ramelteon as a positron emission tomography probe for imaging melatonin receptors involved in circadian rhythms. Chemical & pharmaceutical bulletin 20110101
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia. Drug, healthcare and patient safety 20110101
Melatonin in Chagas' disease. Possible therapeutic value. Medicina 20110101
Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin. Neuro endocrinology letters 20110101
Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215
Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215
Melatonin alters age-related changes in transcription factors and kinase activation. Neurochemical research 20101201
Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. Advances in therapy 20101101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view. Current drug metabolism 20101101
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. Neurocase 20101001
Melatonin: pharmacological aspects and clinical trends. The International journal of neuroscience 20100901
[The newer sedative-hypnotics]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901
Neurotoxins: free radical mechanisms and melatonin protection. Current neuropharmacology 20100901
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Current neuropharmacology 20100901
Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics. Drug metabolism and disposition: the biological fate of chemicals 20100801
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701
Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. Sleep medicine 20100601
Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep. Sleep 20100601
Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats. Annals of the New York Academy of Sciences 20100601
A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. International clinical psychopharmacology 20100501
Potential use of melatonergic drugs in analgesia: mechanisms of action. Brain research bulletin 20100316
MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus). Endocrinology 20100201
Melatonin agonists and insomnia. Expert review of neurotherapeutics 20100201
Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications. The Journal of neuropsychiatry and clinical neurosciences 20100101
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC medicine 20100101
Diagnosis and treatment of chronic insomnia. Annals of Indian Academy of Neurology 20100101
Insomnia medication use and the probability of an accidental event in an older adult population. Drug, healthcare and patient safety 20100101
Indian research on sleep disorders. Indian journal of psychiatry 20100101
Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings. Brain research 20091103
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20091101
Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon. The Journal of pharmacology and experimental therapeutics 20090901
Anticonvulsant effects of the selective melatonin receptor agonist ramelteon. Epilepsy & behavior : E&B 20090901
Treatment of sleep dysfunction and psychiatric disorders. Current treatment options in neurology 20090901
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20090901
Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem). P & T : a peer-reviewed journal for formulary management 20090901
Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090815
[A novel therapeutic drug: ramelteon]. Nihon rinsho. Japanese journal of clinical medicine 20090801
Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture. Psychopharmacology 20090701
Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat. Neuroscience letters 20090626
Emerging therapies for sleep disorders. British journal of hospital medicine (London, England : 2005) 20090601
Ramelteon: a review of its therapeutic potential in sleep disorders. Advances in therapy 20090601
Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests. Prescrire international 20090601
Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis. Current medical research and opinion 20090501
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study. The Journal of clinical psychiatry 20090401
[Objection to a conclusion in Medicinske Nyheder]. Ugeskrift for laeger 20090330
The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Sleep & breathing = Schlaf & Atmung 20090301
Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Human psychopharmacology 20090301
Ramelteon for the treatment of insomnia in menopausal women. Menopause international 20090301
Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep 20090301
Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215
Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215
Let there be sleep--on time. Lancet (London, England) 20090207
The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101
The effects of ramelteon in a first-night model of transient insomnia. Sleep medicine 20090101
Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS neuroscience & therapeutics 20090101
Melatonin and melatonergic drugs on sleep: possible mechanisms of action. The International journal of neuroscience 20090101
New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatric disease and treatment 20090101
Comparative tolerability of newer agents for insomnia. Drug safety 20090101
Drugs associated with more suicidal ideations are also associated with more suicide attempts. PloS one 20090101
Algorithms for the assessment and management of insomnia in primary care. Patient preference and adherence 20090101
Can improving sleep influence sleep-disordered breathing? Drugs 20090101
Neurophysiology of sleep and wakefulness: basic science and clinical implications. Current neuropharmacology 20081201
Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20081015
Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat. Critical care medicine 20081001
Melatonin and its agonists: an update. The British journal of psychiatry : the journal of mental science 20081001
The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity. Sleep 20081001
Ramelteon: new drug. Insomnia: no role for risky placebos. Prescrire international 20081001
Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells. Neuroscience 20080909
Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat. Journal of pineal research 20080901
Ramelteon: a novel approach in the treatment of insomnia. The Annals of pharmacotherapy 20080901
Sleep dysfunction in heart failure. Current treatment options in neurology 20080901
Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep? Journal of sleep research 20080901
Possibility that certain hypnotics might cause cancer in skin. Journal of sleep research 20080901
Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep & breathing = Schlaf & Atmung 20080801
Efficacy and clinical safety of ramelteon: an evidence-based review. Sleep medicine reviews 20080801
Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells. Neuroscience letters 20080704
Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Clinical therapeutics 20080701
Pharmacotherapy for insomnia. Clinics in geriatric medicine 20080201
A review of ramelteon in the treatment of sleep disorders. Neuropsychiatric disease and treatment 20080201
[Drugs for insomnia and improving quality of life (QOL): research and development of ramelteon, an MT1/MT2-receptor agonist]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080101
Ramelteon: a melatonin receptor agonist for the treatment of insomnia. Journal of postgraduate medicine 20080101
Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. Travel medicine and infectious disease 20080101
Melatonergic drugs in clinical practice. Arzneimittel-Forschung 20080101
Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial. Critical care (London, England) 20080101
Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders. Current topics in medicinal chemistry 20080101
Ramelteon: a review of its use in insomnia. Drugs 20080101
Indiplon in the treatment of sleep disorders. Neuropsychiatric disease and treatment 20071201
In search of novel and therapeutically significant melatoninergic ligands. Recent patents on CNS drug discovery 20071101
Design and synthesis of new N1 and C3-substituted 4-fluoroindolic melatoninergics. Current drug discovery technologies 20071001
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20071001
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep & breathing = Schlaf & Atmung 20070901
Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. The American journal of geriatric pharmacotherapy 20070901
Eszopiclone for late-life insomnia. Clinical interventions in aging 20070901
Ramelteon: a novel hypnotic indicated for the treatment of insomnia. Psychiatry (Edgmont (Pa. : Township)) 20070901
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815
Treatment options for insomnia. American family physician 20070815
Putting 'sleepdriving' and new safety warning in perspective. The Johns Hopkins medical letter health after 50 20070801
Eszopiclone: its use in the treatment of insomnia. Neuropsychiatric disease and treatment 20070801
New perspectives for the treatment of disorders of sleep and arousal. Annales pharmaceutiques francaises 20070701
Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Current medical research and opinion 20070601
The management of insomnia in the older adult. Medicine and health, Rhode Island 20070601
Hypnotic sedative drugs. Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20070601
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia. Current medical research and opinion 20070501
Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. Journal of clinical pharmacology 20070401
Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon. Nature clinical practice. Neurology 20070401
Putting insomnia to rest. The Nurse practitioner 20070401
Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy 20070101
[Recent and potential drugs for treatment of insomnia]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070101
Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS drugs 20070101
[Melatonin, melatonin receptor agonists and tryptophan as sleep aids]. Pharmazie in unserer Zeit 20070101
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Primary care companion to the Journal of clinical psychiatry 20070101
Greater incidence of depression with hypnotic use than with placebo. BMC psychiatry 20070101
Role of the melatonin system in the control of sleep: therapeutic implications. CNS drugs 20070101
[New hypnotics: perspectives from sleep physiology]. Vertex (Buenos Aires, Argentina) 20070101
Treating insomnia: Current and investigational pharmacological approaches. Pharmacology & therapeutics 20061201
Pharmacologic management of insomnia: past, present, and future. The Psychiatric clinics of North America 20061201
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Archives of general psychiatry 20061001
Ramelteon for insomnia in two youths with autistic disorder. Journal of child and adolescent psychopharmacology 20061001
Ramelteon for the treatment of insomnia. Clinical therapeutics 20061001
A new sleeping pill. The Harvard mental health letter 20061001
Treatment of sleep dysfunction and psychiatric disorders. Current treatment options in neurology 20060901
Associated Professional Sleep Societies--SLEEP 2006 20th Anniversary Meeting. 17-22 June 2006, Salt Lake City, UT, USA. IDrugs : the investigational drugs journal 20060901
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II. Journal of psychiatric practice 20060901
New drugs 06, part II. Nursing 20060801
Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice. Neuroscience letters 20060724
Ramelteon: a novel treatment for the treatment of insomnia. Expert review of neurotherapeutics 20060701
Searching for new options for treating insomnia: are melatonin and ramelteon beneficial? Journal of psychiatric practice 20060701
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep medicine 20060601
Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies. Behavioral neuroscience 20060601
Management of chronic insomnia in elderly persons. The American journal of geriatric pharmacotherapy 20060601
Depression and sleep: pathophysiology and treatment. Dialogues in clinical neuroscience 20060601
Consultation corner. Are the new sleep aids right for you? The Johns Hopkins medical letter health after 50 20060401
Potential therapeutic use of melatonin in migraine and other headache disorders. Expert opinion on investigational drugs 20060401
Ramelteon (rozerem) a novel approach for insomnia treatment. The Nurse practitioner 20060401
Practical considerations of new drugs: new choices for old problems. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401
Ramelteon: profile of a new sleep-promoting medication. Drugs of today (Barcelona, Spain : 1998) 20060401
Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. Journal of clinical pharmacology 20060201
A look back at the most influential drug approvals of 2005. The Nurse practitioner 20060201
Recommendations for assessing insomnia. The Nurse practitioner 20060201
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep medicine 20060101
New drugs: ramelteon, tipranavir, nepafenac, and deferasirox. Journal of the American Pharmacists Association : JAPhA 20060101
Use of sleep-promoting medications in nursing home residents : risks versus benefits. Drugs & aging 20060101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20060101
Melatonin and sleep in aging population. Experimental gerontology 20051201
Ramelteon (Rozerem) for insomnia. The Medical letter on drugs and therapeutics 20051107
Fresh from the pipeline: Ramelteon. Nature reviews. Drug discovery 20051101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20051001
New drugs and dosage forms. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050915
Recent advances in melatonin receptor ligands. Archiv der Pharmazie 20050601
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20050401
Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep 20050301
Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. Journal of biological rhythms 20050201
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 20050201
TAK-375 Takeda. Current opinion in investigational drugs (London, England : 2000) 20050101
Ramelteon: TAK 375. Drugs in R&D 20050101
Ramelteon. CNS drugs 20050101
Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. The Journal of clinical psychiatry 20050101
Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. The Journal of clinical psychiatry 20050101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20041201
Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys. Brain research 20041119
Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. Sleep medicine 20041101
The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. Sleep 20041101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20041101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20040101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20031101
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. Journal of medicinal chemistry 20020912

© 2019 Angene International Limited. All rights Reserved.